Legend Biotech Corp Earnings

Legend Biotech Corp’s revenue jumped 37.22% since last year same period to $255.95Mn in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated 31.22% jump in its revenue since last 3-months.

Legend Biotech Corp’s net profit fell -591.47% since last year same period to $-125.82Mn in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated -24.68% fall in its net profits since last 3-months.

Legend Biotech Corp’s net profit margin fell -403.9% since last year same period to -49.16% in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated 4.99% jump in its net profit margins since last 3-months.

Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a 67.83% jump from last quarter’s estimates.

Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.04.

Legend Biotech Corp’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Legend Biotech Corp has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.